A different view on the platelet aggregation inhibitor clopidogrel – a well-suitable anti-oedema agent in a preclinical model of brain injury?

2019 ◽  
Vol 82/115 (5) ◽  
pp. 526-532
Author(s):  
Mehmet Yalcin Gunal ◽  
Burak Yulug ◽  
Berrak Calglayan ◽  
Mehmet Ozansoy ◽  
Ulkan Kilic ◽  
...  
Keyword(s):  
Brain Injury ◽  
Platelet Aggregation ◽  
Preclinical Model ◽  
Platelet Aggregation Inhibitor ◽  
Aggregation Inhibitor

scholarly journals Echistatin. A potent platelet aggregation inhibitor from the venom of the viper, Echis carinatus.

1988 ◽  
Vol 263 (36) ◽  
pp. 19827-19832 ◽  
Author(s):  
Z R Gan ◽  
R J Gould ◽  
J W Jacobs ◽  
P A Friedman ◽  
M A Polokoff
Keyword(s):  
Platelet Aggregation ◽  
Platelet Aggregation Inhibitor ◽  
Echis Carinatus ◽  
Aggregation Inhibitor

scholarly journals Screening Test for Platelet Aggregation Inhibitor in Natural Products. The Active Principle of Anemarrhenae Rhizoma

1988 ◽  
Vol 108 (6) ◽  
pp. 555-561 ◽  
Author(s):  
AKIRA NIWA ◽  
OSAMU TAKEDA ◽  
MASAKO ISHIMARU ◽  
YASUKO NAKAMOTO ◽  
KAZUO YAMASAKI ◽  
...  
Keyword(s):  
Natural Products ◽  
Platelet Aggregation ◽  
Screening Test ◽  
Active Principle ◽  
Platelet Aggregation Inhibitor ◽  
Aggregation Inhibitor

Animal Pharmacokinetics and Interspecies Scaling from Animals to Man of Lamifiban, a New Platelet Aggregation Inhibitor

1996 ◽  
Vol 48 (6) ◽  
pp. 573-577 ◽  
Author(s):  
THIERRY LAVE ◽  
ALPHONSE SANER ◽  
PHILIPPE COASSOLO ◽  
R. BRANDT ◽  
ANNE H. SCHMITT-HOFFMANN ◽  
...  
Keyword(s):  
Platelet Aggregation ◽  
Interspecies Scaling ◽  
Platelet Aggregation Inhibitor ◽  
Aggregation Inhibitor ◽  
Animal Pharmacokinetics

Product licences and devious promotion

1990 ◽  
Vol 28 (5) ◽  
pp. 20-20
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Platelet Aggregation ◽  
Unstable Angina ◽  
Platelet Aggregation Inhibitor ◽  
Aggregation Inhibitor

Platet 300 Cleartab (Nicholas) is an effervescent buffered aspirin formulation which the maker has described as “a new cardiovascular-specific presentation of aspirin “and” the only platelet aggregation inhibitor to be licensed for use following acute myocardial infarction, or in patients with unstable angina, to reduce the risk of infarction”.

Sign in / Sign up

Export Citation Format

Share Document